BKMC vs. BOUT
BKMC (BNY Mellon US Mid Cap Core Equity ETF) and BOUT (Innovator IBD Breakout Opportunities ETF) are both Mid Cap Growth Equities funds - BKMC tracks the Morningstar US Mid Cap Index while BOUT tracks the IBD Breakout Stocks Total Return Index. Both are passively managed. Over the past 5 years, BKMC returned 7.85%/yr vs 8.25%/yr for BOUT. A 0.75 correlation means they provide meaningful diversification when combined. BKMC charges 0.04%/yr vs 0.80%/yr for BOUT.
Performance
BKMC vs. BOUT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BKMC achieves a 11.31% return, which is significantly lower than BOUT's 31.39% return.
BKMC
- 1D
- -0.34%
- 1M
- 3.45%
- YTD
- 11.31%
- 6M
- 11.40%
- 1Y
- 23.02%
- 3Y*
- 16.09%
- 5Y*
- 7.85%
- 10Y*
- —
BOUT
- 1D
- -0.01%
- 1M
- 5.85%
- YTD
- 31.39%
- 6M
- 30.30%
- 1Y
- 35.27%
- 3Y*
- 17.42%
- 5Y*
- 8.25%
- 10Y*
- —
BKMC vs. BOUT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
BKMC BNY Mellon US Mid Cap Core Equity ETF | 11.31% | 8.74% | 13.78% | 17.50% | -16.03% | 23.83% | 45.93% |
BOUT Innovator IBD Breakout Opportunities ETF | 31.39% | -6.77% | 18.82% | 13.27% | -22.60% | 22.69% | 66.35% |
Correlation
The correlation between BKMC and BOUT is 0.73, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.73 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.79 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.79 |
Correlation (All Time) Calculated using the full available price history since Apr 13, 2020 | 0.75 |
The correlation between BKMC and BOUT has been stable across timeframes, ranging from 0.73 to 0.79 - a consistent structural relationship.
BKMC vs. BOUT - Sectors Allocation Comparison
Sectors
BKMC
BOUT
Industrials
Technology
Financial Services
Healthcare
Consumer Cyclical
Real Estate
Basic Materials
Consumer Defensive
Communication Services
Energy
Utilities
Industrials
BKMC
BOUT
Technology
BKMC
BOUT
Financial Services
BKMC
BOUT
Healthcare
BKMC
BOUT
Consumer Cyclical
BKMC
BOUT
Real Estate
BKMC
BOUT
Basic Materials
BKMC
BOUT
Consumer Defensive
BKMC
BOUT
Communication Services
BKMC
BOUT
Energy
BKMC
BOUT
Utilities
BKMC
BOUT
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BKMC vs. BOUT — Risk / Return Rank
BKMC
BOUT
BKMC vs. BOUT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for BNY Mellon US Mid Cap Core Equity ETF (BKMC) and Innovator IBD Breakout Opportunities ETF (BOUT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BKMC | BOUT | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.53 | 1.71 | -0.17 |
Sortino ratioReturn per unit of downside risk | 2.26 | 2.33 | -0.07 |
Omega ratioGain probability vs. loss probability | 1.27 | 1.30 | -0.03 |
Calmar ratioReturn relative to maximum drawdown | 2.36 | 3.01 | -0.66 |
Martin ratioReturn relative to average drawdown | 9.06 | 9.00 | +0.06 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BKMC | BOUT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.53 | 1.71 | -0.17 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.42 | 0.43 | 0.00 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.82 | 0.41 | +0.41 |
Drawdowns
BKMC vs. BOUT - Drawdown Comparison
The maximum BKMC drawdown since its inception was -25.02%, smaller than the maximum BOUT drawdown of -36.75%. Use the drawdown chart below to compare losses from any high point for BKMC and BOUT.
Loading charts...
Drawdown Indicators
| BKMC | BOUT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -25.02% | -36.75% | +11.73% |
Max Drawdown (1Y)Largest decline over 1 year | -9.82% | -11.76% | +1.94% |
Max Drawdown (3Y)Largest decline over 3 years | -23.68% | -25.31% | +1.63% |
Max Drawdown (5Y)Largest decline over 5 years | -25.02% | -28.28% | +3.26% |
Current DrawdownCurrent decline from peak | -0.34% | -0.01% | -0.33% |
Average DrawdownAverage peak-to-trough decline | -6.55% | -12.29% | +5.74% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.55% | 3.93% | -1.38% |
Volatility
BKMC vs. BOUT - Volatility Comparison
The current volatility for BNY Mellon US Mid Cap Core Equity ETF (BKMC) is 4.16%, while Innovator IBD Breakout Opportunities ETF (BOUT) has a volatility of 5.96%. This indicates that BKMC experiences smaller price fluctuations and is considered to be less risky than BOUT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BKMC | BOUT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.16% | 5.96% | -1.80% |
Volatility (6M)Calculated over the trailing 6-month period | 10.93% | 16.05% | -5.12% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.12% | 20.79% | -5.67% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.77% | 19.48% | -0.71% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.16% | 22.93% | -3.77% |
BKMC vs. BOUT - Expense Ratio Comparison
BKMC has a 0.04% expense ratio, which is lower than BOUT's 0.80% expense ratio.
Dividends
BKMC vs. BOUT - Dividend Comparison
BKMC's dividend yield for the trailing twelve months is around 1.38%, more than BOUT's 0.26% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
BKMC BNY Mellon US Mid Cap Core Equity ETF | 1.38% | 1.35% | 1.54% | 1.38% | 1.63% | 1.15% | 0.86% | 0.00% | 0.00% |
BOUT Innovator IBD Breakout Opportunities ETF | 0.26% | 0.34% | 0.60% | 1.32% | 1.35% | 0.00% | 0.00% | 0.00% | 0.22% |
Frequently Asked Questions
BKMC and BOUT have a correlation of 0.73, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BOUT has higher volatility (5.96%) compared to BKMC (4.16%). In terms of maximum drawdown, BKMC dropped -25.02% vs BOUT's -36.75%.
On 5-year performance, BOUT leads with 8.25% vs 7.85% for BKMC. On fees, BKMC is cheaper at 0.04% per year. On volatility, BKMC has been the lower-risk option at 4.16%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, BOUT has performed better with a 8.25% return vs 7.85%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
BKMC is cheaper with a 0.04% expense ratio, compared with 0.80% for BOUT.
BKMC has the higher dividend yield at 1.38%, compared with 0.26% for BOUT.
BKMC tracks Morningstar US Mid Cap Index, while BOUT tracks IBD Breakout Stocks Total Return Index. They also come from different issuers: BNY Mellon and Innovator. Their fees differ too: 0.04% for BKMC and 0.80% for BOUT.
BOUT currently has the higher Sharpe Ratio (1.71 vs 1.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BKMC and BOUT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer